Pomegranate juice (PJ) has higher polyphenol content and antioxidative activity than any other fruit juice. We used a pomegranate polyphenol concentrate (PPC) from pomegranate juice and investigated its inhibitory effects and mechanism of action using a contact hypersensitivity (CHS) test. The ear swelling induced by 2,4-dinitrofluorobenzene (DNFB) was inhibited in the PPC-treated group compared to that in the control group. Antigen-specific IgG1 was lower in the PPC-treated group than in the control group; however, serum antigen-specific IgG2a was not different.
Introduction
Allergic contact dermatitis (ACD) is one of the most common skin diseases that are caused by delayed-type hypersensitivity responses to antigens that come into contact with the skin (Kaplan et al., 2012) . Small organic molecules that are chemically reactive with proteins form the most important category of contact allergens. They bind to self-proteins to generate immunogenic antigens through a process termed haptenization (Meglio et al., 2011) . Contact allergens are common in cosmetics, personal care products, and jewelry. Examples of common allergens are organic chemicals such as those found in fragrances and dyes, and inorganic chemicals such as nickel (Peiser et al., 2012) .
Contact hypersensitivity (CHS) is an experimental animal model for human ACD (Honda et al., 2013) . CHS is characterized by T-cell mediated antigen-specific skin inflammation induced by topical skin contact with haptens in previously sensitized hosts.
The CHS response develops in two phases: an afferent phase and an efficient phase. The afferent phase is induced by initial skin contact with the hapten. Skin dendritic cells capture the hapten and subsequently migrate to the draining lymph nodes where they prime specific T cells. These T cells differentiate into CHS effectors in 5-7 days, which recirculate through the blood. The efficient phase develops after the second skin contact to the same ETs belong to the chemical class of hydrolysable tannins and pomegranate contains ETs such as punicalagin and punicalin (Landete, 2011) . The bioavailability of ETs from PJ has been studied in human subjects. The ETs were hydrolyzed to yield ellagic acid (EA), which was further metabolized in the gastrointestinal tract by the colon microflora to chiefly urolithin derivatives (mainly urolithin A, UA) (Cerdá et al., 2004; Seeram et al., 2006) . ETs, EA, and UA have been demonstrated to possess various biological properties, including antioxidant, anticancer, anti-atherosclerotic and anti-inflammatory activities in in vitro and in vivo studies (Heber, 2008; Larrosa, 2010) . Therefore, a number of biological properties of pomegranate are believed to be related to ETs and their derivatives .
To the best of our knowledge, however, the effects of pomegranate polyphenols in CHS have not been investigated. In the present study, we used a pomegranate polyphenol concentrate (PPC) from pomegranate juice and investigated its inhibitory effects and mechanisms of action on CHS.
Materials and Methods
Pomegranate polyphenol concentrate A commercial pomegranate aril extract (from Iran), which was chromatographed over Diaion HP-20 (Sigma-Aldrich, St. Louis, MO, USA) to remove sugar (Kawakami et al., 2014) , was used as PPC in the present study. The obtained PPC contained 59.5% phenolics, which were determined by the Folin-Denis method using ethyl gallate as a standard. The detailed polyphenolic compounds in PPC were reported previously (Kawakami et al., 2014; Ito et al., 2014) .
Animals Female BALB/c mice (6 weeks old, 15-20 g body weight) were purchased from Japan SLC (Hamamatsu, Japan). The mice were housed in a room at 25 ± 2℃ with a 12-h light/dark cycle, and provided acidified water and MF diet (Oriental Yeast, Contact hypersensitivity test The mice were divided into two groups, which were provided acidified water (control group, n = 6) or water supplemented with 0.2% PPC (PPC-treated group, n = 6), respectively. The mice were sensitized on day 0 by applying 100 μL 0.5% 2,4-dinitrofluorobenzene (DNFB, Kanto Chemical, Tokyo, Japan) diluted in acetone/olive oil (4:1) on the shaved dorsal skin. In the 0.5% DNFB challenge experiment, the mice were challenged by the application of 20 μL 0.5% DNFB on both sides of the ears on day 7. In the 0.15% DNFB challenge experiment, the mice were challenged by application of 20 μL 0.15% DNFB on both sides of the ears on days 7 and 14. The ear thickness was measured using a soft touch micrometer (CLM1-15 QM, Mitsutoyo, Tokyo, Japan). All animal experimental procedures were performed under sevoflurane anesthesia (Maruishi Pharmaceutical, Osaka, Japan). Statistical analysis The data represent the mean ± SD. The statistical significance of two groups was analyzed by a Student's t-test using the Origin 8.5 software (OriginLab, Northampton, MA, USA). The data were considered significantly different at p < 0.05.
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Results and Discussion
Suppressive effects of PPC on DNFB-induced ear swelling in mice In the 0.5% DNFB challenge experiment, the sensitized mice were challenged with 0.5% DNFB on day 7, and the ear thickness was measured as a function of time (Fig. 1A) . The ear swelling induced by 0.5% DNFB was significantly inhibited in the PPC-treated group compared to that in the control group. In the 0.15% DNFB challenge experiment, the sensitized mice were challenged with 0.15% DNFB on days 7 and 14, and the ear thickness was measured as a function of time (Fig. 1B) . The ear swelling was significantly inhibited in the PPC-treated group compared to that in the control group on day 8 (24 h after the first challenge) and on day 16 (48 h after the second challenge).
Commonly, a CHS response is induced by application of DNFB to the ear of DNFB-sensitized mice. The degree of ear swelling correlates with the intensity of the effector response and the swelling peaks 24-48 h after the challenge (Honda et al., 2013) .
Therefore, these results indicated that CHS responses were suppressed by oral feeding of PPC. Figure 2A and B show DNP-specific IgG1 and Repeated DNFB-applications induce DNP-specific IgG1 (Th2-type) and IgG2a (Th1-type) in mice (Chapat et al., 2004) . The present study indicates that oral feeding of PPC inhibits haptenspecific IgG1 production, but not IgG2a production, induced by skin sensitization with DNFB. The number of IFN-γ-producing cells was not different between the PPC-treated and control groups, but that of the IFN-γ-producing CD4 + cells was significantly increased in the PPCtreated group compared to that in the control group. In contrast, the numbers of both IL-4-producing cells and IL-4-producing CD4 + cells were not different between the PPC-treated and control groups (Fig. 4) . These results indicate that the number of IFN-γ-producing CD4 + cells (Th1) was increased, while that of IL-4-producing CD4 + cells (Th2) was not altered in the PPC-treated group compared to that in the control group. In other words, the Th1/Th2 balance might be altered toward the Th1-dominant state by oral feeding of PPC. This could be a reason for the observation that oral feeding of PPC inhibited hapten-specific serum IgG1 production but not IgG2a production (Fig. 2C) . Gao et al. (2005) In the present study, the auricular application of 0.15% DNFB was repeated twice and DNP-specific IgE was not detected in the sera of mice. Gao et al. (2004) reported that DNP-specific serum IgE was detected after more than five auricular applications of 0.15% DNFB. This could be a reason why serum IgE was not detected in our animal model. Furthermore, in our previous study, we demonstrated that ET metabolites such as urolithin A inhibited IgE-mediated allergic responses in an in vitro model system. The metabolites highly suppressed antigen-induced degranulation and secretion of allergy-related cytokines (IL-4 and TNF-α) in RBL-2H3 cells (Nagano et al., 2012) . These results suggest that PPC is a potential therapeutic method for treating not only ACD but also atopic dermatitis.
Inhibition of hapten-specific IgG responses in mice by oral feeding of PPC
Effect of PPC feeding on the activation of splenic cells
The number of IL-10-producing cells was not different between the PPC-treated and control groups (Fig. 4A) , while that of IL-10-producing CD4 + cells was significantly increased in the PPCtreated group compared to that in the control group (Fig. 4B ).
These results suggest that IL-10-producing CD4 + cells induced by oral feeding of PPC contribute to the observed reduction of CHS responses. The main function of IL-10 appears to be the prevention of extensive tissue damage after inflammation and infection (Saraiva and O'Garra, 2010) . IL-10 is an anti-inflammatory cytokine and has a crucial role in terminating the CHS response (Honda et al., 2011) . Duan et al. (2011) reported that orally administrated glucosylceramide increased IL-10 in the spleen at 24 h after the DNFB challenge, while the level of IL-10 in the ears
was not different at 24 h after the DNFB challenge. We also measured the IL-10 level in the ears of PPC-treated and control groups by ELISA at 24 h after the second challenge in the 0.15% DNFB challenge experiment, and no significant differences were observed between the two groups (data not shown). In summary, our data provide evidence that oral feeding of PPC suppresses CHS and antigen-specific IgG1 production in BALB/c mice. The number of splenic IL-10-producing CD4 + T cells was increased by oral feeding of PPC. These results suggest that pomegranate juice consumption may be of therapeutic use for ACD.
